Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.87%378.34M | 10.61%99.84M | 15.17%99.24M | 10.06%93.05M | 3.39%86.22M | 9.79%344.37M | 10.27%90.26M | 1.88%86.17M | 7.71%84.54M | 21.35%83.39M |
Operating revenue | 9.87%378.34M | 10.61%99.84M | 15.17%99.24M | 10.06%93.05M | 3.39%86.22M | 9.79%344.37M | 10.27%90.26M | 1.88%86.17M | 7.71%84.54M | 21.35%83.39M |
Cost of revenue | -4.16%233.68M | 1.72%61.07M | 3.18%60.84M | -6.83%57.44M | -14.01%54.34M | 10.16%243.83M | 1.15%60.04M | 0.00%58.96M | 12.23%61.65M | 31.39%63.19M |
Gross profit | 43.89%144.66M | 28.25%38.77M | 41.14%38.4M | 55.52%35.61M | 57.82%31.88M | 8.90%100.53M | 34.30%30.23M | 6.20%27.21M | -2.83%22.9M | -2.06%20.2M |
Operating expense | 10.02%150.99M | 37.24%39.8M | 10.04%38.34M | 10.50%39.66M | -11.50%33.2M | -3.42%137.24M | -17.77%29M | -6.74%34.84M | 4.62%35.89M | 6.65%37.51M |
Selling and administrative expenses | 10.01%144.14M | 38.87%38.08M | 10.05%36.6M | 10.64%37.94M | -12.58%31.52M | -3.02%131.02M | -19.13%27.42M | -6.67%33.26M | 5.58%34.29M | 8.99%36.05M |
-Selling and marketing expense | 23.75%45.09M | 44.42%11.32M | 44.57%13.17M | 24.31%11.51M | -11.12%9.1M | -23.74%36.44M | -18.90%7.84M | -24.96%9.11M | -26.00%9.26M | -24.00%10.23M |
-General and administrative expense | 4.72%99.04M | 36.66%26.77M | -2.98%23.43M | 5.59%26.43M | -13.16%22.42M | 8.32%94.58M | -19.23%19.59M | 2.79%24.15M | 25.38%25.03M | 31.65%25.82M |
Research and development costs | 10.25%6.85M | 8.76%1.71M | 9.97%1.74M | 7.46%1.71M | 15.22%1.68M | -11.18%6.21M | 16.48%1.58M | -8.17%1.58M | -12.51%1.6M | -30.39%1.46M |
Operating profit | 82.75%-6.33M | -183.73%-1.03M | 100.75%57K | 68.86%-4.05M | 92.40%-1.32M | 26.27%-36.7M | 109.63%1.23M | 34.96%-7.64M | -20.96%-12.99M | -19.00%-17.31M |
Net non-operating interest income expense | 288.85%508K | 2,518.75%387K | 448.15%94K | 115.00%6K | 86.63%-25K | -130.88%-269K | -102.91%-16K | -119.29%-27K | -125.00%-40K | -950.00%-187K |
Non-operating interest income | ---- | ---- | ---- | --6K | ---- | ---- | ---- | ---- | ---- | ---- |
Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --40K | ---- |
Total other finance cost | -288.85%-508K | -2,518.75%-387K | -448.15%-94K | ---- | -86.63%25K | 130.88%269K | --16K | --27K | ---- | --187K |
Other net income (expense) | 89.68%-226K | -112.86%-149K | 108.23%33K | 93.17%-25K | 97.19%-38K | -2.19M | -70K | -137.28%-401K | -162.35%-366K | -1,528.92%-1.35M |
Special income (charges) | --0 | --0 | --0 | --0 | --0 | ---2.21M | ---101K | ---357K | ---397K | ---1.35M |
-Less:Restructuring and merger&acquisition | --0 | --0 | --0 | --0 | --0 | --2.21M | --101K | --357K | --397K | --1.35M |
Other non- operating income (expenses) | -1,606.67%-226K | -580.65%-149K | 175.00%33K | -180.65%-25K | -1,800.00%-38K | --15K | --31K | 73.96%-44K | -94.72%31K | 97.59%-2K |
Income before tax | 84.55%-6.05M | -169.20%-791K | 102.28%184K | 69.66%-4.06M | 92.69%-1.38M | 19.93%-39.16M | 109.11%1.14M | 31.48%-8.06M | -34.07%-13.4M | -29.04%-18.85M |
Income tax | 0.00%75K | 19K | -45.71%19K | -35.00%13K | 25.00%25K | -31.82%75K | 0 | 75.00%35K | 0.00%20K | 0.00%20K |
Net income | 84.39%-6.12M | -170.87%-810K | 102.04%165K | 69.61%-4.08M | 92.56%-1.4M | 19.95%-39.24M | 109.08%1.14M | 31.30%-8.1M | -34.00%-13.42M | -29.00%-18.87M |
Net income continuous Operations | 84.39%-6.12M | -170.87%-810K | 102.04%165K | 69.61%-4.08M | 92.56%-1.4M | 19.95%-39.24M | 109.08%1.14M | 31.30%-8.1M | -34.00%-13.42M | -29.00%-18.87M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 84.39%-6.12M | -170.87%-810K | 102.04%165K | 69.61%-4.08M | 92.56%-1.4M | 19.95%-39.24M | 109.08%1.14M | 31.30%-8.1M | -34.00%-13.42M | -29.00%-18.87M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 84.39%-6.12M | -170.87%-810K | 102.04%165K | 69.61%-4.08M | 92.56%-1.4M | 19.95%-39.24M | 109.08%1.14M | 31.30%-8.1M | -34.00%-13.42M | -29.00%-18.87M |
Basic earnings per share | 85.71%-0.06 | -200.00%-0.01 | 101.82%0.0016 | 71.43%-0.04 | 95.00%-0.01 | 20.75%-0.42 | 107.14%0.01 | 30.77%-0.09 | -27.27%-0.14 | -25.00%-0.2 |
Diluted earnings per share | 85.71%-0.06 | -200.00%-0.01 | 101.75%0.0016 | 71.43%-0.04 | 95.00%-0.01 | 20.75%-0.42 | 107.14%0.01 | 30.77%-0.09 | -27.27%-0.14 | -25.00%-0.2 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |